Screener
Opus Genetics IRD Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Opus Genetics’s reported figures.
Based on the most recent quarter.
The source filing: Opus Genetics’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034084
FAQ
- What is Opus Genetics's current ratio?
- Opus Genetics (IRD) reported current ratio of 7.1× in Q1 2026.
- How has Opus Genetics's current ratio changed year-over-year?
- Opus Genetics's current ratio increased by 260.8% year-over-year, from 2× to 7.1×.
- What is the long-term trend for Opus Genetics's current ratio?
- Over 5 years (2020 to 2025), Opus Genetics's current ratio has grown at a 3.0% compound annual growth rate (CAGR), from 5.5× to 6.4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Opus Genetics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude